Tata Capital’s IPO Draws Goldman Sachs, Morgan Stanley Funds


Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here.

Tata Capital Ltd.’s $1.7 billion initial public offering attracted anchor investors including funds managed by Morgan Stanley, Goldman Sachs Group Inc. and Nomura Holdings Inc. as well as domestic mutual funds and insurers.

The company allocated 46.4 billion rupees ($523 million) of shares to the investors ahead of its listing, which opens for public subscription on Monday, according to an exchange filing confirming an earlier Bloomberg News report.

Life Insurance Corp. of India received the biggest allocation, taking 15% of the anchor shares, while funds managed by ICICI Prudential Asset Management Co., HDFC Asset Management Co., Aditya Birla Sun Life Asset Management Co., DSP Asset Managers Pvt. and Whiteoak Capital also participated in the anchor allotment.

Tata Capital allocated 142.4 million shares to anchor investors at 326 rupees apiece. The offering saw robust participation from domestic institutional investors, a statement from the shadow lender showed.

The listing is set to be the country’s largest since Hyundai Motor India Ltd.’s $3.3 billion offering last year, and comes as the nation heads into what could be a record month for IPOs.

Tata’s offering will involve the sale of as many as 475.8 million new and existing shares by Tata Capital, its parent and International Finance Corp., according to the IPO prospectus.

Tata Capital will start taking orders from the broader public from Monday, with shares being offered at 310 rupees to 326 rupees apiece through Wednesday. That would value the shadow lender at as much as 1.4 trillion rupees. The shares are scheduled to begin trading on Oct. 13.

Of the total number of shares being sold in the IPO, half will be earmarked for qualified institutional buyers, 35% for retail investors and the rest for non-institutional investors, including wealthy individuals. As much as 60% of the institutional portion can be allocated to anchor investors, according to the prospectus.

(Updates with details of anchor share allotment in first, second and third paragraphs.)

More stories like this are available on bloomberg.com


Related Posts

Force Motors share price gains 11% on strong Q3 performance, crosses ₹22,000 mark for first time

Force Motors shares extended their winning run to a fourth straight day on Thursday, February 5, surging another 11% to hit the day’s high of ₹22,200 even as the broader…

Raja Venkatraman’s recommends three stocks for 5 February

Stock market recap: The Indian stock market ended with modest gains on Wednesday, 4 February, tracking mixed global cues. Sensex rose 79 points, or 0.09%, to end at 83,817.69, while…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Immortality delayed: Is Novak Djokovic’s window for Slam No. 25 fast closing in Carlos Alcaraz-Jannik Sinner era?

  • By admin
  • February 5, 2026
  • 0 views
Immortality delayed: Is Novak Djokovic’s window for Slam No. 25 fast closing in Carlos Alcaraz-Jannik Sinner era?

‘Thank you, Pakistan’: Bangladesh sports adviser sparks BCB-PCB collusion buzz after India boycott call

  • By admin
  • February 5, 2026
  • 0 views
‘Thank you, Pakistan’: Bangladesh sports adviser sparks BCB-PCB collusion buzz after India boycott call

Bangladesh have mixed feelings about Pakistan’s boycott stand: ‘Wanted to challenge India’s dominance’

  • By admin
  • February 5, 2026
  • 2 views
Bangladesh have mixed feelings about Pakistan’s boycott stand: ‘Wanted to challenge India’s dominance’

Force Motors share price gains 11% on strong Q3 performance, crosses ₹22,000 mark for first time

  • By admin
  • February 5, 2026
  • 2 views
Force Motors share price gains 11% on strong Q3 performance, crosses ₹22,000 mark for first time

Eli Lilly gaining in GLP-1 market over Novo Nordisk, earnings show

  • By admin
  • February 5, 2026
  • 3 views
Eli Lilly gaining in GLP-1 market over Novo Nordisk, earnings show

Imran Khan’s comeback film absent from Netflix 2026 slate for this reason; ‘no official word from Netflix’, says team

  • By admin
  • February 5, 2026
  • 4 views
Imran Khan’s comeback film absent from Netflix 2026 slate for this reason; ‘no official word from Netflix’, says team